New hope for celiac sufferers: experimental drug enters testing
NCT ID NCT06982963
Summary
This study is testing whether a new drug called FB102 can help adults with celiac disease better tolerate accidental gluten exposure. Participants will take either the drug or a placebo while following their gluten-free diet, then undergo a controlled gluten challenge. The goal is to see if FB102 reduces intestinal damage and symptoms when gluten is accidentally consumed.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CELIAC DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Royal Melbourne Hospital
RECRUITINGMelbourne, Australia
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.